TLCM
NVLN

Tiger Legatus Capital Management’s Novelion Therapeutics Inc. Common Shares NVLN Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-450,000
Closed -$4.15M 17
2017
Q2
$4.15M Buy
450,000
+2,148
+0.5% +$19.8K 1.69% 11
2017
Q1
$4.81M Buy
447,852
+127,852
+40% +$1.37M 2.1% 12
2016
Q4
$2.69M Buy
+320,000
New +$2.69M 1% 15